RYTHM (RYM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
The annual meeting is scheduled for June 16, 2026, and will be held virtually, with shareholders able to vote online, by phone, or by mail.
Shareholders will vote on electing seven directors, ratifying the auditor, and amending the equity incentive plan.
Only shareholders of record as of April 20, 2026, are entitled to vote, with 2,149,128 shares outstanding.
Voting matters and shareholder proposals
Proposals include electing seven directors for one-year terms, ratifying GuzmanGray as auditor for 2026, and amending the 2022 Omnibus Equity Incentive Plan to add 115,000 shares.
The board recommends voting FOR all proposals.
No other business matters may be raised at the meeting as no additional proposals were submitted.
Board of directors and corporate governance
The board consists of seven members, with a majority deemed independent under Nasdaq standards.
Three standing committees: Audit, Compensation, and Nominating and Corporate Governance, all composed of independent directors.
A special committee was formed in 2025 to review transactions with Green Thumb.
The board combines the roles of Chairman and CEO, currently held by Benjamin Kovler.
Directors are required to attend annual meetings and adhere to a code of ethics and insider trading policy.
Latest events from RYTHM
- Stockholders approved the issuance of common stock, with no questions raised during the meeting.RYM
AGM 2026 - Revenue and profitability soared on licensing and beverage growth, but regulatory risks persist.RYM
Q2 2026 - Shareholders will vote on issuing shares that could give Green Thumb Industries over 90% control.RYM
Proxy filing - Shareholders will vote on a proposal that could give Green Thumb Industries over 90% control.RYM
Proxy filing - All proposals passed as the company targets THC market growth with strong brands and zero debt.RYM
AGM 2026 - Rising THC demand, regulatory shifts, and strong licensing revenue drive growth and market reach.RYM
Investor presentation - Q1 2026 net income $19.9M, 78% margin, revenue $13.3M, Q2 outlook $22M, strong licensing growth.RYM
Q1 2026 - Virtual meeting to elect directors, ratify auditor, and expand equity plan on June 16, 2026.RYM
Proxy filing - Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 2025